Shin Nippon Biomedical Laboratories Dividends and Buybacks
Dividend criteria checks 2/6
Shin Nippon Biomedical Laboratories is a dividend paying company with a current yield of 2.15% that is well covered by earnings.
Key information
2.2%
Dividend yield
n/a
Buyback Yield
Total Shareholder Yield | n/a |
Future Dividend Yield | 2.9% |
Dividend Growth | 19.7% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | 38% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, SBLO.F has been paying a dividend for less than 10 years.
Growing Dividend: SBLO.F's dividend payments have increased, but the company has only paid a dividend for 4 years.
Dividend Yield vs Market
Shin Nippon Biomedical Laboratories Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (SBLO.F) | 2.2% |
Market Bottom 25% (US) | 1.4% |
Market Top 25% (US) | 4.2% |
Industry Average (Life Sciences) | 0.5% |
Analyst forecast (SBLO.F) (up to 3 years) | 2.9% |
Notable Dividend: SBLO.F's dividend (2.15%) is higher than the bottom 25% of dividend payers in the US market (1.57%).
High Dividend: SBLO.F's dividend (2.15%) is low compared to the top 25% of dividend payers in the US market (4.85%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (37.9%), SBLO.F's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: SBLO.F is paying a dividend but the company has no free cash flows.